Safety and health care group Halma (LON:HLMA) has splashed another £132 million on M&A with the acquisition of French firm Dreampath Diagnostics. The deal takes Halma’s spend in the first four months of its current financial year to over £250 million. Big spender Dreampath is the leading provider of automated systems which enable anatomical pathology … Continue reading Halma splashes the cash on more M&A